Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.07.2023 | Case report

Cisplatin/doxorubicin/methotrexate

Various toxicities: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Tian D, et al. Analysis of the Efficacy of Multidrug Combination Chemotherapy Regimens for Osteosarcoma and the Management of Chemotherapeutic Reactions. Evidence-Based Complementary and Alternative Medicine 2022 : 1-6, Jan 2022. Available from: URL: http://doi.org/10.1155/2022/6510429 Tian D, et al. Analysis of the Efficacy of Multidrug Combination Chemotherapy Regimens for Osteosarcoma and the Management of Chemotherapeutic Reactions. Evidence-Based Complementary and Alternative Medicine 2022 : 1-6, Jan 2022. Available from: URL: http://​doi.​org/​10.​1155/​2022/​6510429
Metadaten
Titel
Cisplatin/doxorubicin/methotrexate
Various toxicities: 2 case reports
Publikationsdatum
01.07.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-42220-x

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Multiple drugs

Case report

Immune-globulin

Case report

Multiple drugs